Investigational Drugs, Biological Products, and Devices - Right to Try Act

HB 584 Investigational Drugs, Biological Products, and Devices Right to Try Act

Maryland 2017 Regular Session

Investigational Drugs, Biological Products, and Devices - Right to Try Act
HB-584


About HB-584

Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; requiring a manufacturer of an investigational drug, biological product, or device to notify a specified patient and a specified health care provider of specified side effects or risks; requiring the Office of the Attorney General to develop an informed consent form that meets specified requirements; etc.

  

Bill Texts

Chaptered 06/07/2017

Enrolled 04/10/2017

Engrossed 03/17/2017

Introduced 01/31/2017

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Sponsors (37)

Votes

House Floor - Third Reading Passed (140-0)

04/02/2017

Yeas: 140 | Nays: 0
Support by Party

   

Senate Floor - Third Reading Passed (46-0)

04/01/2017

Yeas: 46 | Nays: 0
Support by Party

   

House Floor - Third Reading Passed (139-0)

03/17/2017

Yeas: 139 | Nays: 0
Support by Party

   

Sponsors by party

     

Bill Sponsors

History

Approved By The Governor - Chapter 771

05/25/2017

Passed Enrolled

04/10/2017

Third Reading Passed (140-0)

04/10/2017

House Concur - Senate Amendments

04/10/2017

Third Reading Passed With Amendments (46-0)

04/07/2017

Second Reading Passed With Amendments

04/06/2017

Favorable With Amendments {967271/1 Report Adopted

04/06/2017

Favorable With Amendments Report By Finance

04/06/2017

Hearing 4/04 At 1:00 P.m.

04/04/2017

First Reading Finance

03/20/2017

Third Reading Passed (139-0)

03/20/2017

Second Reading Passed With Amendments

03/17/2017

Favorable With Amendments {146788/1 Report Adopted

03/17/2017

Favorable With Amendments Report By Health And Government Operations

03/16/2017

Hearing 3/02 At 1:00 P.m.

03/02/2017

Hearing 2/10 At 1:00 P.m.

02/10/2017

Hearing Canceled

02/03/2017

First Reading Health And Government Operations

01/30/2017